TuHURA Biosciences, Inc./NVHURAEarnings & Financial Report
Nasdaq
NextMar 13, 2026
HURA Q3 2025 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
N/A
Net Profit
$-7.1M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-0.14
TuHURA Biosciences, Inc./NV Q3 2025 Financial Summary
TuHURA Biosciences, Inc./NV reported revenue of $0 for Q3 2025, with a net profit of $-7.1M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-7.1M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q3 2025 |
Income Statement
| Q1 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q1 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|
| Assets | $7.4M | $4.1M | $14.6M | $34.6M | $25.7M |
| Liabilities | $1.5M | $2.4M | $4.8M | $15.2M | $8.9M |
| Equity | $5.9M | $1.7M | $9.9M | $19.4M | $16.8M |
Cash Flow
| Q1 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|
| Operating CF | $-3.8M | $-1.9M | $-4.7M | $-6.2M | $-11.1M |